Vasoreactivity in Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension - A Case of Robust Response to Inhaled Nitric Oxide (iNO)

被引：0
|
作者：
Seth, R. [1 ]
Atchley, W. T. [2 ]
Brewer, S. [1 ]
机构：
[1] Univ Arkansas Med Sci, Internal Med, Little Rock, AR USA
[2] Univ Arkansas Med Sci, Pulm & Crit Care Med, Little Rock, AR USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2229
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Vasoreactivity to inhaled nitric oxide does not predict long term survival in pulmonary arterial hypertension
    Jayasekera, Geeshath
    Johnson, Martin
    Church, Colin
    Peacock, Andrew
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [22] COMPARISON OF EFFECTS OF INHALED TREPROSTINIL ON LUNG FUNCTION IN PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND PULMONARY ARTERIAL HYPERTENSION
    Nathan, Steven
    Tapson, Victor
    Ramani, Gautam
    Medarov, Boris
    Levine, Deborah
    Burger, Charles
    El-Kersh, Karim
    Shen, Eric
    Rao, Youlan
    Smith, Peter
    Waxman, Aaron
    CHEST, 2021, 160 (04) : 2244A - 2246A
  • [23] The composite physiological index strongly predicts mortality in interstitial lung disease (ILD) associated pulmonary hypertension (PH-ILD)
    Bax, Simon
    Bredy, Charlene
    Dimopoulos, Kostas
    Kempny, Aleksander
    Devaraj, Anand
    Walsh, Simon
    Jacobs, Joseph
    Nair, Arjun
    Kokosi, Maria
    Keir, Gregory
    Harries, Carl
    Kouranos, Vasillis
    McCabe, Colm
    Li, Wei
    Ahmed, Riaz
    Wilde, Michael
    Wells, Athol
    Wort, John
    Price, Laura
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [24] Vasoreactivity with inhaled nitric oxide and 100% oxygen in patient's with idiopathic pulmonary fibrosis and pulmonary arterial hypertension
    Anand, Wayneinder S.
    Shapiro, Shelley
    Saggar, Rajeev
    Saggar, Rajan
    Belperio, John A.
    Lynch, Joseph P., III
    Zisman, David A.
    CHEST, 2007, 132 (04) : 583S - 583S
  • [25] Inhaled nitric oxide (iNO) prevents hypoxic pulmonary vasoconstriction in lambs with persistent pulmonary hypertension of the newborn (PPHN)
    Lakshminrusimha, S.
    Mathew, B.
    Wynn, K. A.
    Nair, J.
    Ryan, R. M.
    Russell, J. A.
    Swartz, D. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [26] Inhaled nitric oxide in patients with pulmonary hypertension due to valvular heart disease and chronic lung disease
    Sakane, M
    Ishimitsu, T
    Ninomiya, H
    Ohtsu, I
    Saito, T
    Yamaguchi, I
    Hasegawa, S
    Sugishita, Y
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1998, 62 (12): : 877 - 882
  • [27] Inhaled Nitric Oxide for Fibrotic Interstitial Lung Disease: A Step Forward
    Khor, Yet H.
    Adegunsoye, Ayodeji
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2022, 19 (04) : 536 - 538
  • [28] 232 Treatment of Chronic Lung Disease Associated Pulmonary Hypertension with Inhaled Nitric Oxide Administered via Nasal Cpap
    F Sandri
    G Ancora
    G Bronzetti
    M G Capretti
    R Sciutti
    C Massardo
    Pediatric Research, 2004, 56 : 503 - 503
  • [29] Inhaled nitric oxide prevents severe hypoxemia in newborns with acute lung disease and pulmonary hypertension
    Day, RW
    PEDIATRICS, 1998, 101 (06) : 1093 - 1094
  • [30] Inhaled Treprostinil in Pulmonary Hypertension Associated with Lung Disease
    Mariana Faria-Urbina
    Rudolf K. F. Oliveira
    Manyoo Agarwal
    Aaron B. Waxman
    Lung, 2018, 196 : 139 - 146
12345